Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2630 |
|
Actual shortage: | 256 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2365 (90%) | |
Discontinuation Reports |
249 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 246 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
318 (11%) |
|
Overdue reports |
22 (8%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-07-29 | 2021-09-09 | 143250 |
TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2021-07-29 | 2021-08-13 | 143246 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2021-07-29 | 2021-09-30 | 143242 |
TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2021-07-29 | 2022-02-05 | 143239 |
TEVA-FLUVOXAMINE | 50MG | TABLET | Resolved | 2021-07-29 | 2022-04-28 | 143236 |
TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-07-22 | 2021-09-02 | 142908 |
TEVA-GABAPENTIN | 800MG | TABLET | Resolved | 2021-07-22 | 2021-09-02 | 142905 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2021-07-22 | 2021-09-30 | 142902 |
TEVA-ATENOLOL | 100MG | TABLET | Resolved | 2021-07-22 | 2021-08-13 | 142899 |
TEVA-VORICONAZOLE | 50MG | TABLET | Resolved | 2021-07-15 | 2021-09-02 | 142628 |
TEVA-IMATINIB | 100MG | TABLET | Resolved | 2021-07-15 | 2021-08-13 | 142625 |
TEVA-CITALOPRAM | 40MG | TABLET | Resolved | 2021-07-15 | 2022-02-17 | 142622 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2021-07-15 | 2021-09-02 | 142619 |
TEVA-BISOPROLOL | 5MG | TABLET | Resolved | 2021-07-15 | 2021-09-09 | 142616 |
TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-07-15 | 2021-08-13 | 142613 |
TEVA-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-07-15 | 2021-09-09 | 142610 |
TEVA-ONDANSETRON | 4MG | TABLET | Resolved | 2021-07-15 | 2023-04-28 | 142607 |
TEVA-ONDANSETRON | 8MG | TABLET | Resolved | 2021-07-15 | 2023-04-28 | 142604 |
TEVA-ROPINIROLE | 2MG | TABLET | Avoided shortage | 2021-07-15 | 2021-07-15 | 142581 |
TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2021-07-15 | 2021-07-15 | 142578 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14060 |
TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14052 |
TEVA-CIPROFLOXACIN | 500MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14049 |
NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |